Fermenta Biotech Ltd · BSE:FERMENTA
Fermenta Biotech — H1 FY2026 Earnings Presentation
14 slides from Fermenta Biotech's earnings presentation, Nov 12, 2025
Slide 1: BSE intimation letter for investor presentation H1/FY26
Fermenta Biotech Limited CIN: L99999MH1951PLC008485 Regd. Office: A - 1501, Thane One, DIL Complex, Ghodbunder Road, Majiwade, Thane (W) - 400 610, Maharashtra, India. Tel. : +91-22-6798 0888 Email : info@fermentabiotech.com, Website. : www.fermentabiotech.com Ref: F.No.: 908 November 12, 2025 Corpo
Slide 2: H1/FY26 presentation
Fermenta Biotech Ltd H1/FY26 presentation 12 November 2025
Slide 3: Disclaimer
Disclaimer By viewing this presentation, the recipient agrees that neither Fermenta Biotech Limited (“FBL”) nor any of its affiliates, directors, officers, employees, or representatives shall be liable for any loss, damage, or liability arising directly or indirectly from the use of or reliance on t
Slide 4: Best-in-class scientifically-validated nutritional ingredients
Fermenta provides best-in-class, scientifically-validated nutritional ingredients for the world’s leading brands in the pharmaceutical, dietary supplements, food and beverage, veterinary, and animal feed industries. Our edge? Decades of expertise in global-scale, complex manufacturing, and research-
Slide 5: Q2/H1FY26 Highlights
Q2/H126 Highlights Financials (consolidated) with Real Estate Performance Q2FY25 H1FY26 Human nutrition segment volumes grew 74% over H1FY25. INR 135.7 crore INR 280.7 crore Animal nutrition segment volumes grew 6% and average realization Revenue (up 39% YoY) (up 57% YoY) rose 35% over H1FY25. Germa
Slide 6: Lines of Business
Lines of Business Nutrition Primary revenue source focused on nutritional ingredients for health and wellness industries Vitamin D3 - Human Vitamin D3 - Animal Others Premium supplements, food Specialized formulations for Vitamin D analogs and specialized fortification, and pharmaceuticals livestock
Slide 7: Revenue Mix (Consolidated)
Revenue Mix (Consolidated) H1FY26 H1FY25 YoY change Geographical Revenue Mix (INR crore) (INR crore) (%) (consolidated) excluding real estate value Nutrition Business unlocking Vitamin D3 – Human 158.8 88.3 +80% Nutrition 17% +1% 18% Vitamin D3 – Animal 46.2 32.2 +44% Nutrition 21% Others 15.2 19.6
Slide 8: Cash Flow Statement (₹ Crore)
Cash Flow Statement (₹ Crore) Robust Cash Generation on Strong Operating Performance H1FY26 H1FY25 Operating Cash Flow H1 FY26 continued H1 FY25’s turnaround Net Profit 52 6 Operating cash flow rose to ₹38 crore from negative ₹3 Depreciation 11 12 crore, free cash flow improved to ₹26 crore, and net
Slide 9: Cost Breakdown (Without Real Estate)
Cost Breakdown (Without Real Estate) Stable Costs amid Optimized Operating Leverage (% of Revenue) Raw material costs held steady at 38% of revenue, maintaining the efficiency gains Cost Component H1FY26 FY25 FY24 achieved in FY25. Result of optimzed procurement practices and product mix Raw Materia
Slide 10: Performance Ratios (Consolidated)
Performance Ratios (Consolidated) Strong Operations | Enhanced Financial Stability H1 FY 26 FY 25 FY 24 H1 FY26 demonstrated robust financial health and operational Liquidity excellence Current ratio 1.50 1.58 1.40 Quick ratio 0.71 0.87 0.78 EBITDA margin sustained at 26%, interest coverage rose to
Slide 11: Customer Concentration
Customer Concentration Well-Diversified Base with Balanced Revenue Distribution Low single-customer dependency with the largest Mitigating concentration risk while maintaining strong customer contributing only 9% of total revenue. Only 4 client relationships customers account for more than 5% indivi
Slide 12: The Opportunity
The Opportunity Leverage Fermenta’s strengths towards meeting evolving consumer needs and regulatory requirements across diverse markets India Global Innovation Drivers ✓ Preventive health awareness ✓ Nutritional supplements ✓ Nutrigenomics ✓ Growing middle class ✓ Aging drives vitamin D ✓ Natural/o
Slide 13: Fermenta's Value Proposition
Fermenta’s Value Proposition Society Contribute to global health and preventive care through nutritional ingredients Support life productivity across human and animal populations Address environmental challenges with custom and green chemistry solutions Best-in-class, science-backed Market leadershi
Slide 14: Thank you
Thank you Sumesh Gandhi - CFO sumesh.gandhi@fermentabiotech.com Fermenta Biotech Ltd